PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+20.26%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.78B
AUM Growth
+$476M
(+21%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
4.26%
Top 10 Holdings %
Top 10 Hldgs %
41.05%
Holding
1,048
New
64
Increased
345
Reduced
583
Closed
56
Top Buys
| 1 |
NVIDIA
NVDA
|
$15.2M |
| 2 |
Microsoft
MSFT
|
$15.1M |
| 3 |
Apple
AAPL
|
$11.5M |
| 4 |
Shopify
SHOP
|
$10.5M |
| 5 |
Broadcom
AVGO
|
$8.66M |
Top Sells
| 1 |
Salesforce
CRM
|
$2.4M |
| 2 |
Arista Networks
ANET
|
$1.92M |
| 3 |
Snowflake
SNOW
|
$1.37M |
| 4 |
Insmed
INSM
|
$1.26M |
| 5 |
Exxon Mobil
XOM
|
$1.25M |
Sector Composition
| 1 | Technology | 46.81% |
| 2 | Communication Services | 11.24% |
| 3 | Consumer Discretionary | 11.17% |
| 4 | Healthcare | 8.44% |
| 5 | Financials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CGAU
951
Centerra Gold
CGAU
$1.69B
| $127K | ﹤0.01% |
17,610
-507
| -3% | -$3.66K |
|
952
Stoke Therapeutics
STOK
$1.08B
| $125K | ﹤0.01% |
10,986
-1,896
| -15% | -$21.5K |
|
953
NovaGold Resources
NG
$2.75B
| $122K | ﹤0.01% |
29,918
+4,334
| +17% | +$17.7K |
|
|
EXK
954
Endeavour Silver
EXK
$1.78B
| $120K | ﹤0.01% |
24,298
+1,689
| +7% | +$8.31K |
|
955
Apple Hospitality REIT
APLE
$3.09B
| $119K | ﹤0.01% |
10,226
-27
| -0.3% | -$315 |
|
956
KalVista Pharmaceuticals
KALV
$765M
| $113K | ﹤0.01% |
+10,020
| New | +$113K |
|
957
Arvinas
ARVN
$559M
| $111K | ﹤0.01% |
15,122
-15,507
| -51% | -$114K |
|
958
Iovance Biotherapeutics
IOVA
$796M
| $108K | ﹤0.01% |
62,848
-25,691
| -29% | -$44.2K |
|
959
Goodyear
GT
$2.41B
| $108K | ﹤0.01% |
10,389
-1,067
| -9% | -$11.1K |
|
960
Regenxbio
RGNX
$498M
| $106K | ﹤0.01% |
+12,921
| New | +$106K |
|
961
Emergent Biosolutions
EBS
$407M
| $105K | ﹤0.01% |
16,488
-5,504
| -25% | -$35.1K |
|
962
LXP Industrial Trust
LXP
$2.69B
| $103K | ﹤0.01% |
12,454
-513
| -4% | -$4.24K |
|
963
Viavi Solutions
VIAV
$2.62B
| $102K | ﹤0.01% |
10,136
+91
| +0.9% | +$916 |
|
964
Capricor Therapeutics
CAPR
$272M
| $102K | ﹤0.01% |
10,241
-6,867
| -40% | -$68.2K |
|
965
Evolus
EOLS
$486M
| $99.8K | ﹤0.01% |
+10,833
| New | +$99.8K |
|
966
ProPetro Holding
PUMP
$514M
| $99.1K | ﹤0.01% |
16,603
-3,975
| -19% | -$23.7K |
|
967
Trevi Therapeutics
TRVI
$880M
| $98.8K | ﹤0.01% |
+18,059
| New | +$98.8K |
|
968
Nuvation Bio
NUVB
$1.17B
| $92.8K | ﹤0.01% |
47,597
+7,123
| +18% | +$13.9K |
|
969
Payoneer
PAYO
$2.41B
| $91K | ﹤0.01% |
13,286
+953
| +8% | +$6.53K |
|
970
Verastem
VSTM
$650M
| $90.1K | ﹤0.01% |
+21,708
| New | +$90.1K |
|
971
MiMedx Group
MDXG
$1.05B
| $89.5K | ﹤0.01% |
14,654
-525
| -3% | -$3.21K |
|
972
RPC Inc
RES
$1.06B
| $89.2K | ﹤0.01% |
18,864
-208
| -1% | -$984 |
|
973
MindMed
MNMD
$702M
| $89K | ﹤0.01% |
13,707
-3,802
| -22% | -$24.7K |
|
974
Altimmune
ALT
$314M
| $84K | ﹤0.01% |
21,713
-8,046
| -27% | -$31.1K |
|
975
Humacyte
HUMA
$231M
| $81.8K | ﹤0.01% |
39,153
+854
| +2% | +$1.79K |
|